ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00219089
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : May 17, 2017
Sponsor:
Information provided by (Responsible Party):
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2005
  Actual Study Completion Date : August 2005